This refers to the high-profile federal case against Dr. Sanjeev Kumar, a Mayo Clinic-trained Indian-origin gynecologic oncologist in Memphis, TN (Poplar Avenue Clinic), specializing in robotic cancer surgery for gynecologic cancers.

Background on the Case

• Initial sensational allegations (around 2024–early 2025): The DOJ/FBI investigated claims involving human trafficking, sexual assault/rape, and fraud tied to gynecologic procedures. This led to dramatic raids and widespread media coverage labeling it as exploitation of patients.
• Charges evolved: Many of the most serious sex-related/trafficking counts were later dropped or dismissed. The case narrowed to 46 federal counts focused on:
  • Healthcare fraud (billing Medicare/Medicaid for allegedly medically unnecessary procedures).
  • Adulteration/misbranding of medical devices (reusing “single-use” hysteroscopes and other tools meant for disposal or proper reprocessing; storing them unsanitarily).
  • Performing procedures like hysteroscopy (visualizing the uterus with a small scope to check for endometrial issues/cancer) without proper justification or patient notification about device reuse.

Note on colposcopy/hysteroscopy: These are standard tools for cervical/endometrial cancer screening/diagnosis (e.g., abnormal Pap smears, bleeding, high-risk patients). Hysteroscopy is more invasive than a Pap smear but common. Dr. Kumar argued high volume was due to serving many high-risk/Medicare/Medicaid patients in a border area, with rising endometrial cancer linked to obesity. Prosecutors/experts claimed overutilization (e.g., dozens to 100+ unnecessary cases per testimony) and cost-cutting via improper device reuse.

Trial Outcome (as of early 2026)

A federal jury in the Western District of Tennessee convicted him on 40 of 46 counts after a multi-week trial and days of deliberation. This included fraud and device-related violations. Sentencing was pending (mentioned around July in some coverage).2941

Dr. Kumar and supporters (including in the recent Mojo Story/Barkha Dutt interview) call it “false persecution” or prosecutorial overreach:

• Insurance billing disputes retroactively deemed “fraud.”
• No direct patient complaints of sexual assault (patients reportedly unaware their names were used initially).
• Alleged procedural issues (e.g., FBI agent resetting phone/deleting data, jury matters under seal).
• Targeting as a high-volume “outlier” minority/immigrant doctor, while ignoring patient volume and clinical need.26

Official DOJ/FBI view: Patients were exposed to unnecessary invasive procedures with reused/unsanitary single-use devices (risk of infection, etc.), while billing as if new/proper. They sought victim/patient info publicly.28

Broader Context

• US healthcare fraud prosecutions (especially Medicare/Medicaid) are common and can be aggressive, sometimes criticized for “weaponizing” regulations against physicians years later.
• Device reuse rules (FDA single-use labels) are strict for safety.
• Indian-American doctors have faced scrutiny in some billing cases, fueling community narratives of bias (similar to other high-profile examples).
• Defense highlights his reputation as a prolific cancer surgeon and questions the government’s motives/evidence handling.

Is it “false persecution”? It’s contested. The jury sided with the government on most counts after evidence presentation (including expert testimony on unnecessary procedures). However, the shift from trafficking headlines to device/fraud convictions, plus dropped counts and alleged procedural flaws, has led to claims of overreach—especially given no victim-initiated sexual allegations. Appeals or post-trial motions (e.g., new trial requests) are likely.35

This is a complex medical-legal dispute, not settled fact. For the latest, check official DOJ updates or court records (Western District TN). The YouTube video you referenced is an advocacy-style interview presenting Dr. Kumar’s side.